undamentalytics Newsletter

Cerus Corp balance sheet

At the end of fiscal 2025, Cerus Corp had total assets of $222m, total liabilities of $157m and shareholders' equity of $64.2m. It held $20.0m in cash against $84.0m of debt: net debt of $64.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cerus Corp: balance sheet, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents172925272923712314293537493612202016
Receivables—56465671291721253436303031
Inventory—66101315111314141923272940385665
Total current assets—42404478751309490147128183187170144152174157
Goodwill—11111111111111111
Total assets—484549838213910398163166221237218198201222205
Accounts payable—3576105911192224363324222826
Deferred revenue (current)—00000100011112111
Total current liabilities—202126392922272353506079117686410180
Short-term debt—2————————————————
Long-term debt—3———1020———————————
Total debt0578310201930303940557080848464
Total liabilities—242730414045465979108118152150144144157128
Shareholders' equity2124181943429558398557104856853566476
Net debt (negative = net cash)−17−24−18−19−26−13−51−31614363468646447
Shares outstanding——51m56m72m80m99m103m116m137m144m168m174m178m181m186m192m—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CERS vs LMATCERS vs ESTACERS vs KIDSAXGN vs CERS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cerus Corp's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cerus Corp.